improved

Gome Fin Tech Announced Annual Results of 2023

Source Node:
Time Stamp: April 1, 2024 1:23 PM - Modified On: April 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Commercial Factoring Progresses Despite Stability Diversified Businesses Ready for Development HONG KONG, Mar 29, 2024 - (ACN Newswire) - Gome Finance Technology Co., Ltd.(Stock Code:628.HK,“Gome Fin Tech”or “the Company”,with its subsidiaries,the“Group”), announced its audited annual results for the year ended 31 December, 2023 (the “Reporting Period”). In 2023, the global geopolitical risks are frequent, the lack of economic recovery momentum and the widening trend of differentiation among countries are highlighted, and the risk spillover from European and US banks under the global high interest rate environment also casts a

Blockpass Heralds Cutting Edge Compliance Automation – Advanced KYC Bot(TM)

Source Node:
Time Stamp: January 23, 2024 4:57 AM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

HONG KONG, Jan 18, 2024 - (ACN Newswire) - Blockpass is proud to reveal a brand-new automation advancement that will see the KYC experience for its customers improved even further with the introduction of the Advanced KYC Bot(TM). Included as standard for all Managed Service add-on clients, the handy new bot will automate the KYC process even further, reducing the time and effort required for compliance by monitoring and processing flags to KYC profiles. Also available on a standalone basis for Enterprise customers, the Advanced KYC Bot(TM) builds on the capability

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:39 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo

Source Node:
Time Stamp: October 5, 2023 11:22 AM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo Clinical trials, the linchpin of medical research, have long been riddled with inefficiencies, from patient recruitment bottlenecks to data management hurdles. As a technology and banking analyst, I've seen how digital solutions can overhaul entire sectors, offering improved productivity and streamlined processes. It's high time that clinical trials get a dose of such digital innovation, and there's a potent combination on the horizon: digital watermarking coupled with Artificial Intelligence (AI). At first glance, one might wonder: how can a technique often

M88 is the bookmaker you need to experience!

Source Node:
Time Stamp: August 25, 2022 3:52 PM - Modified On: February 26, 2024 - Published By:
Source Cluster:
Republished By Plato

M88 is the abbreviation for Mansion88. This is one of the first bookmakers to operate in the betting market, and this bookmaker M88 was licensed to start operations in Vietnam in 2007. With a history of being one of the pioneers of the field, Surely this house will show you what world-class quality is. Outstanding features of this bookmaker that you will definitely be very satisfied with: Prestige and quality: Since its establishment, M88 has continuously developed and improved its position to always be among the top most prestigious bookmakers

You will definitely love 12Bet!

Source Node:
Time Stamp: August 22, 2022 3:49 PM - Modified On: February 26, 2024 - Published By:
Source Cluster:
Republished By Plato

Although it is a lesser known name than its competitors, bookmaker 12Bet is not inferior as it is also a leading name in the market. Established in 2008, this house has continuously improved to achieve the achievement of being a place worthy of the trust placed by customers today. Therefore, this house will definitely conquer your love. Outstanding features of this bookmaker that you will definitely be very satisfied with: Access links are always open: Certainly, no player will feel satisfied when one day when they access the link to

M88 is the bookie that you are experiencing!

Source Node:
Time Stamp: August 18, 2022 4:53 AM - Modified On: August 18, 2022 - Published By:
Source Cluster:
Republished By Plato

M88 stands for Mansion88. This is one of the first bookmakers operating in the betting market, and in this m88 was licensed to start operating in Vietnam in 2007. With a history of being one of the pioneers of the field, surely. This bookie will surely show you what world class quality is. The outstanding features of this bookie that you are sure to be very satisfied with: Prestige and quality: Since its establishment until now, M88 has constantly developed and improved its position to always stand in the top

OKLink Insights: OKLink releases the Global Crypto Market 2022/Q1 Report

Source Node:
Time Stamp: April 14, 2022 10:13 AM - Modified On: April 14, 2022 - Published By:
Source Cluster:
Republished By Plato

-- Monetary policy greatly affecting Cryptocurrency BEIJING, Apr 13, 2022 - (ACN Newswire) - The OKLink team released the Global Crypto Market 2022/Q1 report on April 10, which contains a thorough review on the market performance of various public blockchain as well as in-depth discussion of popular fields and topics in the first quarter. OKLink: Preparing for a prosperous multi-chain era as Ethereum 2.0 is drawing near. [OKLink Global Crypto 2002/Q1 Report] According to OKLink data, MicroStrategy is by far the largest holder of bitcoin amongst overseas listed companies. It